Home NDC 64406-020 Vumerity
Product NDC 64406-020
11-digit product format 644060020
Labeler code 64406
Product ID 64406-020_25e0bcfe-8df7-4a62-9db1-ba39a266e8bd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name diroximel fumarate
Dosage form CAPSULE
Route ORAL
Labeler Biogen Inc.
Application NDA211855
Marketing category NDA
Marketing start 2019-10-29
Substance DIROXIMEL FUMARATE
Active strength 231 mg/1
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211855-001 VUMERITY DIROXIMEL FUMARATE 231MG CAPSULE, DELAYED RELEASE / ORAL AB RLD, RS 2019-10-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N211855-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211855-001 10080733 2033-09-20 U-1384 Drug substance, Drug product 2019-11-22 N211855-001 9090558 2033-09-20 U-1384 2019-11-22 N211855-001 8669281 2033-10-29 Drug substance, Drug product 2019-11-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N211855-001 VUMERITY 231MG CAPSULE, DELAYED RELEASE / ORAL AB RLD, RS 2019-10-29 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 N211855-001 AB 1 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-01 22:54:32 2026-06 N211855-001 10080733 2033-09-20 U-1384 Drug substance, Drug product 2019-11-22 a50c72e98297…2026-08-01 22:54:32 2026-06 N211855-001 9090558 2033-09-20 U-1384 2019-11-22 a50c72e98297…2026-08-01 22:54:32 2026-06 N211855-001 8669281 2033-10-29 Drug substance, Drug product 2019-11-22 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base Vumerity
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DIROXIMEL FUMARATE 231 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination K0N0Z40J3W Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2261788 Internal RxNorm lookup 2261794 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Action table NDC Effective Action Document Indexing SPL Related label 64406-020-01 2024-08-07 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-03 2024-08-07 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-05 2024-08-07 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-07 2024-08-07 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-01 2024-07-30 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-03 2024-07-30 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-05 2024-07-30 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013 64406-020-07 2024-07-30 C162847 48780-1 1e7a6dab-175b-a2ce-e063-dadaa90aadf7 These highlights do not include all the information needed to use VUMERITY ® safely and effectively. See full prescribing information for VUMERITY. VUMERITY ® (diroximel fumarate) delayed-release capsules, for oral use Initial U.S. Approval: 2013
DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64406-020 VUMERITY (DIROXIMEL FUMARATE) CAPSULE [BIOGEN INC.] 15 Current NDC, Legacy NDC, 8 package rows 20241109_2d74414f-6b83-4ea2-9a95-3cecabbce774.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 64406-020-01 64406002001 1 BOTTLE, PLASTIC in 1 CARTON (64406-020-01) > 106 CAPSULE in 1 BOTTLE, PLASTIC 2019-10-29 0000-00-00 No No Current 64406-020-03 64406002003 1 BOTTLE, PLASTIC in 1 CARTON (64406-020-03) / 120 CAPSULE in 1 BOTTLE, PLASTIC 2019-10-29 0000-00-00 No No Current 64406-020-05 64406002005 1 BOTTLE, PLASTIC in 1 CARTON (64406-020-05) > 106 CAPSULE in 1 BOTTLE, PLASTIC 2019-10-29 0000-00-00 Yes No Current 64406-020-07 64406002007 1 BOTTLE, PLASTIC in 1 CARTON (64406-020-07) / 14 CAPSULE in 1 BOTTLE, PLASTIC 2022-09-01 0000-00-00 Yes No Current